2929
Pharma Foods International Co.,Ltd.
ファーマフーズ
- Industry
- Foods
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Jul 2021
46,752
Jul 2022
60,185
Jul 2023
68,572
Jul 2024
62,147
Jul 2025
65,260
Operating profit(million JPY)
Jul 2021
5,673
Jul 2022
1,080
Jul 2023
3,610
Jul 2024
5,113
Jul 2025
2,367
Operating profit margin(%)
Jul 2021
12.13
Jul 2022
1.79
Jul 2023
5.26
Jul 2024
8.23
Jul 2025
3.63
Profit before tax(million JPY)
Jul 2021
5,765
Jul 2022
1,423
Jul 2023
3,542
Jul 2024
5,034
Jul 2025
2,434
Profit(million JPY)
Jul 2021
3,841
Jul 2022
-374
Jul 2023
3,081
Jul 2024
3,205
Jul 2025
368
Total assets(million JPY)
Jul 2021
20,944
Jul 2022
31,159
Jul 2023
36,232
Jul 2024
36,573
Jul 2025
32,649
Cash and cash equivalents(million JPY)
Jul 2021
9,794
Jul 2022
8,845
Jul 2023
16,306
Jul 2024
15,566
Jul 2025
9,057
Cash flows from operating activities(million JPY)
Jul 2021
5,938
Jul 2022
-6,065
Jul 2023
6,125
Jul 2024
5,486
Jul 2025
-1,092
Cash flows from investing activities(million JPY)
Jul 2021
-442
Jul 2022
-2,539
Jul 2023
-1,013
Jul 2024
-1,390
Jul 2025
-950
Cash flows from financing activities(million JPY)
Jul 2021
1,030
Jul 2022
7,679
Jul 2023
2,341
Jul 2024
-4,842
Jul 2025
-4,467
Return on equity(%)
Jul 2021
57.46
Jul 2022
-4.82
Jul 2023
36.89
Jul 2024
30.22
Jul 2025
3.19
Equity ratio(%)
Jul 2021
40.4
Jul 2022
22.7
Jul 2023
26.6
Jul 2024
31.7
Jul 2025
35.4
Earnings per share(JPY per share)
Jul 2021
132.21
Jul 2022
-12.89
Jul 2023
106.7
Jul 2024
112.71
Jul 2025
12.83
Net assets per share(JPY per share)
Jul 2021
291.25
Jul 2022
243.65
Jul 2023
333.88
Jul 2024
412.71
Jul 2025
399.95
Dividend per share(JPY per share)
Jul 2021
25
Jul 2022
20
Jul 2023
22
Jul 2024
25
Jul 2025
25
Payout ratio(%)
Jul 2021
18.91
Jul 2022
-
Jul 2023
20.62
Jul 2024
22.18
Jul 2025
194.86
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.